After 30 years of use in transplant medicine, EBV-specific T cells offer key lessons for safer, scalable allogeneic cell therapies, writes Ivan Horak, M.D.

What is optogenetics? The Nobel-winning technology uses light to control specific cells, helping scientists understand how ...

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized ...

Italian researchers used sequential statistical design to assemble synthetic microbial communities of acetic acid bacteria, ...

Andrew Huberman, the Stanford neuroscientist, predicts that the world's most powerful AI labs will inevitably pivot to biotech, driven by a ...

A new bibliometric review reveals that artificial intelligence and catalysis, despite explosive individual growth, intersect ...

Richard Socher, co-founder and CEO of Recursive, argues on the Peter Diamandis podcast that while weak forms of recursive self-improvement ...

Genetically modified organisms could become the newest recruits in Minnesota’s long and largely losing battle against ...

Growing inside each of us is a cellular family tree. Every one of the 37 trillion cells in our body is generated from another ...

Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...